BREA, Calif., June 19, 2018 /PRNewswire/ — Beckman Coulter announced today the positive results of a clinical trial suggesting that blood tests may offer key benefits in the initial screening for obstructive sleep apnea. The study, which involved 264 male adult patients from six institutions, revealed that screening for changes in three specific biomarkers may be... Read more
Basel, 19 June 2018 Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology Together, the companies will leverage expertise in genomics and molecular information to enhance the development of personalised medicines and care for patients with cancer Merger focuses on driving ubiquity of Foundation Medicine’s high... Read more
Basel, 19 June 2018 Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology Together, the companies will leverage expertise in genomics and molecular information to enhance the development of personalised medicines and care for patients with cancer Merger focuses on driving ubiquity of Foundation Medicine’s high... Read more
Testing Performed Together with EUROPattern System Can Help Accelerate Lupus Diagnosis WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN Crithidia luciliae immunofluorescence test (CLIFT) and CLIFT sensitive assays have received FDA 510(k) clearance. CLIFT testing is critical in supporting the detection of anti-double stranded... Read more
PARIS, June 18, 2018 /PRNewswire/ — At the International Society of Magnetic Resonance in Medicine Conference (www.ismrm.org), Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360. It is the most advanced research-grade software for preclinical MRI, and has now also been extended to nuclear molecular imaging. ParaVision 360 enables sequential... Read more
PARIS, June 18, 2018 /PRNewswire/ — At the International Society of Magnetic Resonance in Medicine Conference (www.ismrm.org), Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360. It is the most advanced research-grade software for preclinical MRI, and has now also been extended to nuclear molecular imaging. ParaVision 360 enables sequential... Read more
https://www.biomax.com/lib/press-releases/201806_NeuroXM.pdf Read more
AUSTIN, Texas, June 13, 2018 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced the company recently began clinical studies for the Gastrointestinal (GI) Assay on the VERIGENE® II System, its new sample to answer benchtop molecular diagnostic system in development. The VERIGENE System enables clinicians to rapidly identify the pathogens responsible for some of the... Read more
Agilent Companion Diagnostic Gains Expanded FDA Approval in Cervical Cancer PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify cervical cancer patients for treatment with KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., June 12, 2018 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its... Read more
JUNE 7, 2018 • NEWS Advanced Instruments Announces New, Modern Logo Modern font coupled with iconic curve captures company’s legacy and strong focus on innovation NORWOOD, MA- June 7, 2018: Advanced Instruments—a leading developer of scientific and analytical instruments for the clinical, biopharmaceutical, and food-and-beverage industries—unveiled a new, modernized version of its company logo today.... Read more